Some of the key market trends and insights discussed during the webinar included:
- The increased number of filings that ultimately need a greater number of packaging components
- Driving part of this volatility was the observation that price pressure remains prevalent as, when looking at moving average total November 2016 data, while there was a positive increase in total prescription growth of 3.3%; however, there was a decline in revenue growth during the same time period for generic manufacturers of 2.8%
- The significant volatility that generic manufacturers experience within their own portfolio due to drug shortages and frequent changes in market demand
To understand and review additional market trends and insights discussed by the West team during the webinar, click here.